Expanded Surveillance for Pediatric Infectious Diseases
Forecasted
This grant funds a network of U.S. institutions to track and analyze pediatric respiratory and gastrointestinal viruses, evaluating prevention methods and informing public health strategies through hospital and clinic surveillance.
Funder: Centers for Disease Control and Prevention - ERA
Due Dates (Anticipated): December 2026 (Full application deadline)
Funding Amounts: Estimated $850,000–$1,140,000 per award per year; up to $40,000,000 total program funding; 7 awards expected
Summary: Supports a U.S. surveillance network to monitor pediatric respiratory and enteric viral illnesses and evaluate prevention strategies.
Description
This opportunity, offered by the Centers for Disease Control and Prevention (CDC), will fund a network of U.S. institutions to conduct standardized, prospective, active surveillance of pediatric acute respiratory illness (ARI) and acute gastroenteritis (AGE). The program focuses on respiratory and enteric viruses in children seeking healthcare, aiming to generate robust data on the effectiveness of prevention products (such as vaccines for influenza, rotavirus, RSV, etc.) and inform public health strategies.
Applicants must participate in the Core Component (inpatient and emergency department surveillance) and may opt into additional components, including outpatient surveillance and studies on immune response and immunization. Recipients will follow CDC protocols, enroll pediatric patients meeting symptom criteria, and confirm viral infections using approved molecular assays. Data collected will support improved diagnosis, treatment, and prevention recommendations for pediatric viral illnesses.
